Lantheus Exec Capitalizes on PSUs, Sells Shares at Discount – Insider Strategy Signals Confidence Amid Regulatory Scrutiny
Discover how Lantheus insider trades reveal executive confidence and strategic risk‑management amid FDA prospects and regulatory scrutiny.
4 minutes to read